Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis
- 1 October 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 293 (4), G894-G902
- https://doi.org/10.1152/ajpgi.00133.2007
Abstract
Although simple steatosis was originally thought to be a pathologically inert histological change, fat accumulation in the liver may play a critical role not only in disease initiation, but also in the progression to nonalcoholic steatohepatitis and cirrhosis. Therefore, prevention of fat accumulation in the liver may be an effective therapy for multiple stages of nonalcoholic fatty liver disease (NAFLD). Promising beneficial effects of betaine supplementation on human NAFLD have been reported in some pilot clinical studies; however, data related to betaine therapy in NAFLD are limited. In this study, we examined the effects of betaine on fat accumulation in the liver induced by high-sucrose diet and evaluated mechanisms by which betaine could attenuate or prevent hepatic steatosis in this model. Male C57BL/6 mice weighing 20 ± 0.5 g (means ± SE) were divided into four groups (8 mice per group) and started on one of four treatments: standard diet (SD), SD+betaine, high-sucrose diet (HS), and HS + betaine. Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous). Long-term feeding of high-sucrose diet to mice caused significant hepatic steatosis accompanied by markedly increased lipogenic activity. Betaine significantly attenuated hepatic steatosis in this animal model, and this change was associated with increased activation of hepatic AMP-activated protein kinase (AMPK) and attenuated lipogenic capability (enzyme activities and gene expression) in the liver. Our findings are the first to suggest that betaine might serve as a therapeutic tool to attenuate hepatic steatosis by targeting the hepatic AMPK system.Keywords
This publication has 41 references indexed in Scilit:
- Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathwayJournal of Hepatology, 2007
- AMP-activated protein kinase signaling in metabolic regulationJCI Insight, 2006
- Homocysteine Activates cAMP-response Element Binding Protein in HepG2 Through cAMP/PKA Signaling PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- AMP-activated protein kinase: balancing the scalesBiochimie, 2005
- S-adenosylhomocysteine sensitizes to TNF-? hepatotoxicity in mice and liver cells: A possible etiological factor in alcoholic liver diseaseHepatology, 2004
- Recent Advances in Alcoholic Liver Disease II. Minireview: molecular mechanisms of alcoholic fatty liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- AMP-activated protein kinase and hepatic genes involved in glucose metabolismBiochemical Society Transactions, 2003
- Prevention of bile acid-induced apoptosis by betaine in rat liverHepatology, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959